Actavis is buying Warner Chilcott in an all-stock deal valued at about $8.5 billion that would create the third-biggest specialty pharmaceutical company in the U.S. market.

Technology - Business

May 20, 2013 not rated yet 0

(Phys.org) —Every available cancer drug is susceptible to resistance, according to Mansoor Amiji, Distinguished Professor and chair of the Department of Pharmaceutical Sciences. Tumors grow more quickly ...

Nanotechnology - Bio & Medicine

Mar 19, 2013 5 / 5 (5) 1

(Phys.org)—Though we may not realize it, our minds spend a lot of time dis­carding infor­ma­tion. More like a big-​​box store than a box of choco­lates, life is con­stantly throwing us infor­ma­tion we don't ...

Chemistry - Other

Jan 14, 2013 not rated yet 0

Traditional drug manufacturing is a time-consuming process. Active pharmaceutical ingredients are synthesized in a chemical manufacturing plant and then shipped to another site, where they are converted into ...

Chemistry - Other

Mar 12, 2012 5 / 5 (4) 0

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research (FMI) publish exciting new results on the regulation of cell fate in the scientific journal Nature. They identified ...

Biology - Cell & Microbiology

Dec 15, 2011 5 / 5 (1) 0 |

An international team led by scientists from the Genomics Institute of the Novartis Research Foundation (GNF) and The Scripps Research Institute has discovered a family of chemical compounds that could lead ...

Chemistry - Biochemistry

Nov 17, 2011 3 / 5 (2) 2 |

UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.

Medicine & Health - Medications

May 29, 2011 5 / 5 (3) 1

(AP) -- Vaccine makers said this month they plan to make a record amount of flu vaccine for this fall and winter - enough for more than half the population. It's just not clear all those people will need ...

Medicine & Health - Diseases, Conditions, Syndromes

May 27, 2011 not rated yet 0

(PhysOrg.com) -- Scientists from the Friedrich Miescher Institute for Biomedical Research have identified a new and important molecular player in glioblastoma. The amount of the MNK1 kinase is not only dramatically ...

Medicine & Health - Cancer

Mar 18, 2011 not rated yet 0

(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine ...

Chemistry - Biochemistry

Feb 04, 2011 5 / 5 (3) 0

(AP) -- Doctors are reporting a stunning setback for a promising new approach for fighting breast cancer.

Medicine & Health - Cancer

Dec 09, 2010 not rated yet 0

(PhysOrg.com) -- Giant Swiss pharmaceutical company Novartis AG, based in Basel, is developing a pill containing an embedded microchip, which it hopes to submit for regulatory approval in Europe within 18 ...

Medicine & Health - Medications

Nov 10, 2010 4.9 / 5 (18) 10 |

Swiss pharmaceutical company Novartis said Saturday that the US drug Food and Drug Administration had approved a drug for treating certain benign brain tumours which previously required surgery.

Medicine & Health - Medications

Oct 30, 2010 not rated yet 0

(AP) -- Novartis Pharmaceuticals Corp. will pay $422.5 million in penalties for marketing an epilepsy medicine for unapproved uses and for paying kickbacks to doctors to prescribe it and five other drugs, ...

Medicine & Health - Medications

Sep 30, 2010 5 / 5 (1) 0

(AP) -- CVS Caremark Corp. said Wednesday it will give away up to $5 million in seasonal flu vaccinations to people without health insurance.

Medicine & Health - Health

Sep 08, 2010 not rated yet 0